The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. [electronic resource]
Producer: 19740119Description: 652-7 p. digitalISSN:- 0098-7484
- Adult
- Anticholesteremic Agents -- therapeutic use
- Clinical Trials as Topic
- Clofibrate -- therapeutic use
- Coronary Disease -- drug therapy
- Dextrothyroxine -- therapeutic use
- Drug Evaluation
- Drug Therapy, Combination
- Estrogens, Conjugated (USP) -- administration & dosage
- Follow-Up Studies
- Humans
- Lipoproteins, LDL -- blood
- Lipoproteins, VLDL -- blood
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Nicotinic Acids -- therapeutic use
- Placebos
- Recurrence
- Sodium
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.